Recruiting Pulmonary Hypertension Studies in London
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
The Phase 1 part of the study is a dose escalation of STP938 as monotherapy. The Phase 2 part of the study is cohort expansion of STP938 as a monotherapy in 5 different B and T cell lymphomas....
Study of ATX-01 in Participants With DM1
The goal of this clinical trial is to test ATX-01 in participants with myotonic dystrophy type 1 (DM1). The main question it aims to answer is if ATX-01 is safe and well tolerated. The trial will comp...
NS-050/NCNP-03 in Boys With DMD (Meteor50)
This is a Phase 1/2 study of Multiple-Ascending Dose (MAD) levels for 12 weeks of treatment followed by 24 weeks of open-label treatment with a selected dose of NS-050/NCNP-03 administered once weekly...
About Pulmonary Hypertension Clinical Trials in London
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 3 pulmonary hypertension clinical trials recruiting participants in London, . These studies are seeking a combined 256 participants. Research is being sponsored by Step Pharma, SAS, ARTHEx Biotech S.L., NS Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in London — FAQ
Are there pulmonary hypertension clinical trials in London?
Yes, there are 3 pulmonary hypertension clinical trials currently recruiting in London, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in London?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the London research site will contact you about next steps.
Are clinical trials in London free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many London studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 3 active trials in London are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov